Search

everythinglearnresearchcommunity

for

Search:↓

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Better diagnosis and control of thallium poisoning are needed to prevent severe outcomes.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

Ritlecitinib can help about 14,000 people with severe hair loss.

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

A man was poisoned with thallium, treated successfully, but still had some nerve issues after 6 months.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

A woman with Rhupus and Rowell syndrome was treated successfully with medication adjustments.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

The rs1128977 gene variant may affect cholesterol and body measurements.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Cedrol may be an effective treatment for colorectal cancer.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Systemic retinoids do not increase COVID-19 risk or severity.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.